The mission of the University of Pennsylvania Molecular Profiling Core is to provide quality services for molecular biology assays that are conducted with highly parallel or high-throughput technologies. These services include assistance with experimental design and resource assessment, sample preparation, assay performance, and data management and analysis. Professional laboratory technologists and bioinformaticists working as a team throughout an investigator's project provide these resources. The Molecular Profiling Core enables a wide variety of researchers to observe global nucleic acid patterns, including expression levels of all RNA transcripts in a sample, genetic variability throughout the genomic DNA sequence of an individual or population, and epigenetic modifications across the genome. These patterns, whether genome-wide or targeted to a specific set of markers, can be compared between control and treated/affected cell types in experiments that range from cell cultures to diagnostic or prognostic patient samples.
The Specific Aims are:
Aim 1 : To provide guidance and training on the capabilities, advantages, and disadvantages of various genomics protocols and analyses for musculoskeletal research through formal educational enrichment programs and one-on-one interactions.
Aim 2 : To provide expertise and service for whole-genome and targeted RNA profiling assays of musculoskeletal tissues.
Aim 3 : To provide expertise and service for whole-genome and targeted DNA profiling assays of musculoskeletal tissues.
Aim 4 : To provide bioinformatics services and training appropriate for analyzing the data produced in Aims 2 and 3.
Aim 5 : To provide funding for development of new assays, projects and collaborations and to facilitate development of preliminary and/or feasibility data for investigators.
Successful completion of these aims will significantly enhance the environment and the capabilities of researchers at the University of Pennsylvania, leading to new approaches to address musculoskeletal disorders and new collaborations between Center faculty who may have not previously included genomics or other molecular profiling approaches in their musculoskeletal research programs.
|Tian, Zuozhen; Ma, Xiaoyuan; Yasen, Miersalijiang et al. (2018) Intervertebral Disc Degeneration in a Percutaneous Mouse Tail Injury Model. Am J Phys Med Rehabil 97:170-177|
|Chandra, Abhishek; Wang, Luqiang; Young, Tiffany et al. (2018) Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis. FASEB J 32:52-62|
|Li, Qing; Wang, Chao; Han, Biao et al. (2018) Impacts of maturation on the micromechanics of the meniscus extracellular matrix. J Biomech 72:252-257|
|Qu, Feini; Li, Qing; Wang, Xiao et al. (2018) Maturation State and Matrix Microstructure Regulate Interstitial Cell Migration in Dense Connective Tissues. Sci Rep 8:3295|
|Lindborg, Carter M; Brennan, Tracy A; Wang, Haitao et al. (2018) Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP). Bone 109:153-157|
|Amalfitano, Matthew; Fyfe, Billie; Thomas, Sumi V et al. (2018) A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings. Bone 109:56-60|
|Freedman, Benjamin R; Rodriguez, Ashley B; Leiphart, Ryan J et al. (2018) Dynamic Loading and Tendon Healing Affect Multiscale Tendon Properties and ECM Stress Transmission. Sci Rep 8:10854|
|Rooney, Sarah Ilkhanipour; Torino, Daniel J; Baskin, Rachel et al. (2018) Doxycycline improves cage activity, but not exercised, supraspinatus tendon and muscle in a rat model. J Biomech 80:79-87|
|Brennan, Tracy A; Lindborg, Carter M; Bergbauer, Christian R et al. (2018) Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP). Bone 109:259-266|
|Martin, John T; Gullbrand, Sarah E; Mohanraj, Bhavana et al. (2017) * Optimization of Preculture Conditions to Maximize the In Vivo Performance of Cell-Seeded Engineered Intervertebral Discs. Tissue Eng Part A 23:923-934|
Showing the most recent 10 out of 258 publications